A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.

Background: With the aging of populations worldwide, Alzheimer's disease (AD) has become a concern due to its high prevalence and the continued lack of established treatments. Early diagnosis is required as a preventive intervention to modify the disease's progression. In our previous study, we performed peptidomic analysis of serum samples obtained from AD patients and age-matched healthy subjects to seek peptide biomarker candidates for AD by using BLOTCHIP-MS analysis, and identified four peptides as AD biomarker candidates. Objective: The objective was to validate the serum biomarker peptides to distinguish mild cognitive impairment (MCI) and AD in comparison to cognitively healthy controls using a new peptidome technology, the Dementia Risk Test. Methods: We enrolled 195 subjects with normal cognitive function (NC; n = 70), MCI (n = 55), and AD (n = 70), The concentrations of cognitive impairment marker peptides (Fibrinogen α chain (FAC), Fibrinogen ß chain (FBC), Plasma protease C1 inhibitor (PPC1I), α2-HS-glycoprotein (AHSG)) were quantified by using a selected reaction monitoring assay based on liquid chromatography-MS/MS. Results: The present study confirmed that three peptides, FAC, FBC, and PPC1I, were significantly upregulated during the onset of AD. This three-peptide set was both highly sensitive in determining AD (sensitivity: 85.7%, specificity: 95.7%, AUC: 0.900) and useful in distinguishing MCI (sensitivity: 61.8%, specificity: 98.6%, AUC: 0.824) from NC. Conclusions: In this validation study, we confirmed the high diagnostic potential of the three peptides identified in our previous study as candidate serum biomarkers for AD. The Dementia Risk Test may be a powerful tool for detecting AD-related pathological changes.

THE IMPACT OF TOCILIZUMAB ON THE BIOCHEMICAL MARKER PROCALCITONIN DURING COVID-19 INFECTION.

OBJECTIVE: The aim: The primary objective of our study was to track the TCZ's impact on PCT levels in a cohort of COVID-19 patients who received dexamethasone daily from admission to the day of discharge. PATIENTS AND METHODS: Materials and methods: There were two groups: a treatment group of 40 patients who received tocilizumab and a 40-patient control group that did not receive the medication. Both groups' daily blood culture results and serum procalcitonin biochemical indicators were observed for 20 days, or until discharge or death. After 10 days, non-parametric univariate and linear mixed model analyses were used to compare the two groups' differences. RESULTS: Results: Tocilizumab is administered on Day 5 and greatly reduces procalcitonin. The two groups did not differ in the percentage of positive blood cultures. CONCLUSION: Conclusions: Procalcitonin levels in COVID-19 individuals who have received tocilizumab maybe not a dependable predictor of superinfection with bacteria.

Breed-specific evaluation of serum biochemical markers in canine hip dysplasia observed in a Tornjak dog population.

OBJECTIVE: Canine hip dysplasia (CHD) is a global disease and an improved diagnostic approach to this orthopedic condition is needed, with an emphasis on inexpensive and minimally invasive techniques. This research aimed to determine the differentiating potential of selected biochemical markers in serum between healthy dogs and dogs with hip dysplasia in a breed-specific study that involved the Tornjak dog population. ANIMALS: 99 Tornjak dogs radiographically categorized (Federation Cynologique Internationale procedure and scoring scheme) between December 2019 and April 2021, as having no sign of hip dysplasia or near normal hip joints (nondysplastic group; n = 51) vs mild, moderate, or severe hip dysplasia (dysplastic group; 48). METHODS: Serum concentrations and enzyme activity of the biochemical markers hyaluronic acid (HA), procollagen II C-terminal propeptide (PIICP), and metalloproteinase 9 (MMP9) were compared among adult dogs with or without radiographic hip dysplasia. Statistical tests used to examine the differentiating potential of biochemical markers in Tornjak dog groups were assessed using the Mann-Whitney U test, logistic regression, and receiving operating characteristics (ROC) analysis. RESULTS: Tornjak dogs with radiographic CHD had significantly lower serum concentrations of HA and higher concentrations of PIICP and MMP9 activity compared to dogs with radiographically normal hips (P < .05). Selected biochemical markers could distinguish dogs with radiographic CHD from those without CHD with high sensitivity and specificity. CLINICAL RELEVANCE: These data suggest that the diagnostic technique of measuring serum concentrations of HA, PIICP, and MMP9 activity has a selective ability to distinguish dogs with dysplastic from dogs with normal hips.

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer.

OBJECTIVE: To compare the efficacy of paclitaxel liposomes combined with carboplatin and paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer and assess their effects on serum human epididymis protein 4 (HE4), CA125, CA199, matrix metalloproteinase-2 (MMP2), MMP-7, and MMP-9 levels. METHODS: In this observational study, 102 patients with advanced ovarian cancer were assigned to receive paclitaxel liposomes combined with carboplatin (Group A) or paclitaxel combined with carboplatin (Group B). Clinical efficacy; serum HE4, CA125, CA199, MMP-2, MMP-7, and MMP-9 levels; and the occurrence of adverse reactions were compared between the groups. RESULTS: The overall response rate was significantly higher in Group A than in Group B. After chemotherapy, serum HE4, CA125, CA199, MMP-2, MMP-7, and MMP-9 levels were lower in Group A than in Group B. The incidence of myalgia, dyspnea, nausea and vomiting, facial flushing, peripheral neuropathy, and skin rash was lower in Group A than in Group B. CONCLUSION: Paclitaxel liposomes combined with carboplatin displayed better efficacy in the treatment of advanced ovarian cancer than paclitaxel combined with carboplatin, which might be attributable to reductions in serum marker levels and the occurrence of adverse events.

Effects of vitamin K supplementation on reproductive performance and bone metabolism-related biochemical markers in lactation sows.

OBJECTIVE: This study was conducted to evaluate the effects of vitamin K (VK) supplementation on reproductive performance and bone metabolism-related biochemical markers in sows. METHODS: Twenty-four Large White×Landrace sows (mean parity 4.04) were randomly assigned to two dietary treatments (NC diet, a basal diet with 0.5 mg/kg of VK3; VK diet, a basal diet with 5 mg/kg of VK3) with twelve replicates per treatment and one sow per replicate according to parity. The experiment started on day 107 of gestation and lasted until day 21 of lactation (weaning). RESULTS: We observed that there were no differences (p>0.05) in average daily feed intake, backfat loss of sows, live piglet number at birth and weaning, average birth weight, average weaning weight, and average daily gain of piglets between two treatments. The apparent total tract digestibility of phosphorus was increased (p<0.05) in VK sows compared with NC sows. The serum bone alkaline phosphatase, osteocalcin, type I procollagen aminoterminal peptide, and type I procollagen carboxyl-terminal peptide on day of farrowing were higher (p<0.05) in VK sows than in NC sows. The serum phosphorus, parathyroid hormone, tartrate-resistant acid phosphatase, and tumor necrosis factor-alpha on day of weaning were lower (p<0.05) in VK sows compared with NC sows. CONCLUSION: Therefore, the overall results suggested that increasing dietary VK3 (0.5 to 5 mg/kg) during lactation improved the apparent total tract digestibility of phosphorus and serum bone metabolism biochemical markers in sows.

Biochemical responses as early and reliable biomarkers of organophosphate and carbamate pesticides intoxication: A systematic literature review.

Inhibition of cholinesterase (ChE) activity has been long considered as the main diagnostic method of organophosphate (OP) and carbamate pesticides poisoning; however, it has been shown that ChE activity may also be altered due to exposure to other non-organophosphorus toxicants and variety of different medical conditions. Hence, to avoid misdiagnosis, we aimed to systematically review available documents to look for additional biomarkers of OP and carbamate poisoning. The electronic databases in addition to Google scholar were searched for eligible articles on March 2022 using "organophosphate," "carbamate," and "biomarker" including all their similar terms. After collecting the relevant documents, the data were extracted and described qualitatively. In total, data of 66 articles from 51 human and 15 animal studies were extracted. Findings demonstrated that enzymes such as ß-glucuronidase, neuropathy target esterase, amylase, and lipase, in addition to hematological indicators such as CBC, CRP, lactate dehydrogenase, and CPK have high sensitivity and accuracy in the diagnosis of OP poisoning. Findings suggest that using various markers for diagnosis of OP intoxication is helpful for appropriate management, and early identifying the patients at risk of death. The suggested biomarkers also help to avoid misdiagnosis of OP poisoning with other similar conditions.

Chromogranin B in blood serum of patients with neuroendocrine tumors.

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms from cells of the diffuse neuroendocrine system. Chromogranin B (CgB) is an acidic protein of the granin family, which can be used to detect the tumours of neuroendocrine nature. Analysis of levels and evaluation of the diagnostic efficiency of CgB in the blood serum of patients with NETs of various localizations. Patients with NETs (n=121) without specific treatment were examined. In the study were presented next localizations: 74 - pancreas, 20 - stomach, 12 - large intestine, 15 - other localizations (lungs, mammary gland, prostate gland, NETs with unidentified primary). 54 practically healthy donors were examined as control group. The determination of CgB in blood serum was performed with ELISA method on BEP 2000 analyzer using a standardized test system Human Chromogranin B (USCN, China). CgB levels in common NET group (median 18.9 ng/mL) were statistically significantly higher than in the control group (8.8 ng/mL). The highest median was obtained in group of intestinal NETs (21.2 ng/ml), which exceeded the median of the control group by more than 2.4 times. According to ROC analysis in the common NET group relative to the control group, the area under the curve AUC was 0.88 (95% CI 0.83-0.929). According to cut-off level of CgB - 15.8 ng/ml, the diagnostic sensitivity was 69.4%, with a specificity of 96.3%. The highest diagnostic sensitivity was in the group of the intestinal NETs (75.0%) and pancreas (71.2%). The study showed the significance of CgB as a potential biochemical marker of NETs with various localizations, alternative to CgA.

Detection of urinary cystatin-c in IUGR neonates by immunoblot SDS-PAGE.

BACKGROUND: it is known that intrauterine growth retardation (IUGR) represents a risk factor for the deterioration of renal function as it can adversely impact on the number of nephrons developed in the kidney during nephrogenesis. An interesting molecule is the Cystatin-C (cyst-C): it is considered to have the potency to detect both glomerular and proximal renal injury. Recently, using a quantitative EIA cyst-C detection kit, we found increased levels of cyst-C in the urine of neonates with IUGR. Since cyst-C molecules can be present in both monomer and/or polymer forms, the purpose of this study is to investigate in which forms this molecule is present in the urine of IUGR neonates by Immunoblot SDS-PAGE in order to verify if the presence or absence of a particular type of cyst-C conformation can give more information about the renal functioning. METHODS: urine samples were collected from 64 neonates with IUGR, and 86 healthy controls defined as appropriate for gestational age (AGA). Urinary cyst-C was investigated by the Immunoblot SDS-PAGE. RESULTS: in all urine samples, SDS-PAGE analysis showed a reactivity of the IgG anti cyst-C with a complex of about 70 kDa. The monomer form at 13 KDa appeared in 78% of IUGR neonates and in 12% of AGA neonates. CONCLUSIONS: this study revealed the presence of monomer cyst-C in the urine of IUGR neonates, and suggests an insufficient and/or non-compensatory reabsorption by tubular cells. Monomeric cyst-C can be considered an early biochemical marker to identify and to select IUGR neonates who need to be monitored for risk of renal injury.

Placental growth factor as a predictive marker of preeclampsia - PREBIO study - PREeclampsia BIOchemical study.

INTRODUCTION: To evaluate the clinical utility of placental growth factor (PlGF) for the prediction of preeclampsia (PE). MATERIALS AND METHODS: This prospective cohort study included women divided into three groups: (1) pregnancies without preconceptional risk of developing PE; (2) pregnancies with a preconceptional and/or current risk of developing PE; (3) PE-complicated pregnancies (control group). Blood samples were collected every 4-5 weeks or during hospitalization from early second trimester until delivery in the group 1 and 2, at the diagnosis of PE in the group 3. Plasma levels of PlGF were measured using The Triage PlGF test (Alere) and considered pathological under the 5th centile for gestational age. Sensitivity (Sn), specificity (Sp), positive and negative predictive value (PPV, NPV) were calculated. RESULTS: In group 1, 30% of women (3/10) had pathological test but none of them developed PE (Sp 70%, NPV 100%). In group 2 (n = 75), none of the patients with normal test developed PE (0/24), while 39% of women with PlGF < 5th centile (20/51) developed PE (Sn 100%, Sp 44%, PPV 39%, NPV 100%). In group 3 (n = 11) all women except one had a pathological PlGF test (Sn 90%, PPV 100%). CONCLUSIONS: Our data support recent studies which identify PlGF as a biochemical marker not only of PE, but also of placental dysfunction. In fact, it is useful for ruling out PE in women at risk because of the high Sn and high NPV: a normal PlGF is related with a positive pregnancy outcome. Therefore, the measurement of this biomarker would simplify PE clinical management and would reduce costs.

Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.

BACKGROUND: Oral submucous fibrosis (OSMF) is a potentially malignant disorder of oral mucosa and its malignant transformation rate accounts to about 7%-13%. Oxidative damage and lipid peroxidation plays an important role in OSMF. Lipid peroxidation has not been widely investigated in OSMF patients with respect to clinical staging and histopathological grading. As human saliva is a diagnostic fluid which can be obtained in a noninvasive procedure as compared to the blood for serum analysis, the present study was aimed at evaluating the salivary malondialdehyde (MDA) levels in OSMF and comparison with respect to clinical staging and histopathological grading. AIM: This study aims to evaluate salivary MDA levels in OSMF and compare the levels with respect to clinical and histopathological grading systems. MATERIALS AND METHODS: Forty cases of clinically diagnosed and histopathologically proven cases of OSMF were included for the purpose of this study. As controls 40 age-matched individuals without any systemic disease were selected. Unstimulated whole saliva was collected from each individual, centrifuged and frozen at - 20°C until analysis. Lipid peroxidation products MDA were analyzed by thiobarbituric acid reaction. RESULTS: Salivary MDA levels were significantly increased in OSMF patients compared to controls. The progressively increased salivary MDA levels showed a positive correlation with the clinical stages and histopathological grades of OSMF and the results were statistically significant. CONCLUSION: The increased salivary MDA levels in OSMF patients compared to the control group suggests an increased oxidative stress levels in the potentially malignant disorders such as OSMF. The mean salivary MDA levels were increased significantly as the clinical stage and histopathological grade of OSMF advances, suggesting MDA to be used as a reliable biochemical marker and also a prognostic marker to assess the extent of oxidative damage in OSMF.

Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.

Because of low sensitivity and specificity of the currently available urine biomarkers of bladder cancer (BC) detection and painful cystoscopy procedure. Our study aimed to evaluate expression of urinary exosomal miR-96-5p and miR-183-5p as probable non-invasive and accurate biomarkers for the diagnosis and follow up of BC. Using quantitative real-time polymerase chain reaction; expression of exosomal microRNA (miR)-96-5p and miR- 183-5p in the urine samples of 51 patients with BC, 21 patients with benign urinary bladder lesions and in 24 normal individuals as control group was done. Our study results showed higher expressions of both miR-96-5p and miR-183-5p in urine of BC patients in comparison with control group (P < 0.001 for each). Receiver operating characteristic curve (ROC) analysis showed that each microRNA had good sensitivity and specificity to differentiate BC from non-BC patients miR-96-5p 80.4% and 91.8% and miR-183-5p 78.4% and 81.6% respectively compared to cytology (37.3% and 100%). In addition, it was obvious that the sensitivity of combined miR-96-5p and miR-183-5p for the diagnosis of BC reached 88.2%% and specificity reached 87.8%, which were higher than each one alone. We also found that expression of miR-96-5p and miR-183-5p with high grade, and pathological stage was significantly increased. After surgery, collected urine samples showed significantly lower expression of miR-96-5p-: P < 0.001; and miR-183-5p: P = 0.002. In conclusion, urine miR-96-5p and miR-183-5p are promising tumor biomarkers of BC diagnosis; particularly, when they combined with each other or with urinary cytology.

Biochemical effects of intraoperative cell salvage and autotransfusion during cesarean section: A prospective pilot study.

AIM: Intraoperative cell salvage and autotransfusion (ICSA) is a useful technique for women undergoing cesarean sections who are predicted to experience significant bleeding. This method can reduce allogeneic transfusions as well as its associated risks and costs. Amniotic fluid embolism (AFE) is an abnormal maternal response to ICSA similar to the classic systemic inflammatory response syndrome, but its mechanism is not well understood. This study was conducted to investigate the biochemical aspects of AFE. METHODS: A prospective case-controlled pilot study was conducted in a general perinatal hospital in Japan. ICSA was performed using a two-step retransfusion process. Blood samples were collected presurgery, immediately postsurgery, and 24 h after surgery. Changes in sialyl Tn antigen (STN), complement C3 and C4, fibrinogen, and fibrin degradation product and D-dimer, C1 esterase inhibitor, and interleukin-8 (all considered AFE-related markers) activities were compared between patients who underwent cesarean sections with ICSA (ICSA group) versus without ICSA (control group). RESULTS: Fibrinogen levels were significantly lower in the ICSA group than in the control group before surgery but not immediately after or 24 h after surgery. D-dimer was significantly higher immediately after surgery but not 24 h later. STN was significantly lower only before surgery. None of the AFE-related markers showed significant differences between the groups after 24 h. No adverse events were observed in the ICSA group. CONCLUSIONS: There is no clinical evidence that ICSA alters the biochemical statuses of AFE-related markers in a manner that could lead to adverse maternal responses.

Management of pregnancy blood pressure increase in the emergency room: role of PlGF-based biochemical markers and relative economic impact.

INTRODUCTION: To evaluate the clinical and economic impact of healthcare management of pregnant women with blood pressure increase (BPI) accessing emergency room (ER) and the utility of the introduction of a PlGF-based test in clinical practice. MATERIALS AND METHODS: This retrospective cohort study included women with single pregnancies who performed at least 1 ER access for BPI after the 20th gestational week in 2016. BPI was subsequently classified as significant if associated with preeclampsia (PE) or Fetal Growth Restriction (FGR) and not significant otherwise. Two experts evaluated potential changes in patients' management with the introduction of a PlGF-based test. The direct healthcare cost was estimated. RESULTS: We enrolled 107 patients, of which 30% showed significant BPI (17 PE cases, 13 FGR, and 2 both pathologies). Anamnestic, clinical, and laboratory evaluations were not effective in differentiating between significant and not significant BPI (p-values: .8320, .2856, and .2297, respectively). The introduction of a PlGF-based test would have reduced overtreatment and undertreatment. The test would have avoided 18% of all hospitalizations, 35% of hospitalizations for BPI, 43% of outpatient referrals, and 13% of ER accesses. The number of avoidable accesses was higher in women with not significant BPI. Overall, the mean total cost (from first ER access until delivery) was €2634 per woman and €401 would have been avoidable. CONCLUSION: The clinical integration of PlGF-based tests is advantageous in diagnostic, prognostic and economic terms, as an objective marker of placental dysfunction.

Oxidative Stress Biomarker Decreased in Preterm Neonates Treated With Kangaroo Mother Care.

OBJECTIVE: Due to physiological and metabolic immaturity, prematurely born infants are at increased risk because of maternal separation in many neonatal intensive care units (NICUs). The stress induced from maternal-infant separation can lead to well-documented short-term physiologic instability and potentially lifelong neurological, sociological, or psychological sequelae. Based on previous studies of kangaroo mother care (KMC) that demonstrated improvement in physiologic parameters, we examined the impact of KMC on physiologic measures of stress (abdominal temperature, heart rate, oxygen saturation, perfusion index, near-infrared spectrometry), oxidative stress, and energy utilization/conservation in preterm infants. METHODS: In this randomized, stratified study of premature neonates, we compared the effects on urinary concentrations of biomarkers of energy utilization and oxidative stress of 1 hr of KMC versus incubator care on Day 3 of life in intervention-group babies (n = 26) and control-group babies (n = 25), respectively. On Day 4, both groups received 1 hr of KMC. Urinary samples were collected 3 hr before and 3 hr after intervention/incubator care on both days. Energy utilization was assessed by measures of adenosine triphosphate (ATP) degradation (i.e., hypoxanthine, xanthine, and uric acid). Oxidative stress was assessed using urinary allantoin. Mixed-models analysis was used to assess differences in purine/allantoin. RESULTS: Mean allantoin levels over Days 3 and 4 were significantly lower in the KMC group than in the control group (p = .026). CONCLUSIONS: Results provide preliminary evidence that KMC reduces neonatal oxidative stress processes and that urinary allantoin could serve as an effective noninvasive marker for future studies.

Neutrophil-to-lymphocyte ratio predicts acute appendicitis and distinguishes between complicated and uncomplicated appendicitis: A systematic review and meta-analysis.

OBJECTIVES: to investigate whether Neutrophil-to-lymphocyte ratio (NLR) can predict acute appendicitis and whether it can distinguish between uncomplicated and complicated appendicitis. METHODS: A search of electronic information sources was conducted to identify all studies reporting NLR in patients with clinical suspicion or confirmed diagnosis of acute appendicitis. We considered two comparisons:1) appendicitis versus no appendicitis; 2) uncomplicated appendicitis versus complicated appendicitis. ROC curve analysis was performed to determine cut-off values of NLR for appendicitis and complicated appendicitis. RESULTS: Seventeen studies, enrolling 8,914 patients were included. NLR of 4.7 was cut-off value for appendicitis with sensitivity of 88.89% and specificity of 90.91% with AUC of 0.96. NLR of 8.8 was cut-off value for complicated appendicitis with sensitivity of 76.92% and specificity 100% with AUC of 0.91. NLR >4.7 was predictor of acute appendicitis (OR:128,P < 0.0001) and, NLR >8.8 was predictor of complicated appendicitis (OR:43,P < 0.0001). CONCLUSIONS: NLR predicts both diagnosis and severity of appendicitis. This may have implications for prioritising cases for surgery, for monitoring conservatively treated patients and for patients who do not routinely undergo CT scan (pregnant or paediatric patients).

Diagnosis of acute appendicitis and clinical outcomes following laparoscopic surgery: a cohort study.

BACKGROUND: The clinical assessment of appendicitis remains challenging, especially between genders and across age groups. Negative appendicectomy rates (NARs) can be as high as 43% and are significantly higher in the female population. Evidence suggests blood markers such as white blood cell count (WBC) and C-reactive protein have poor predictive value. There is a lack of regional data assessing workup and outcomes following laparoscopic appendicectomy. METHOD: A multi-centre, retrospective study was performed. A database of adult patients undergoing laparoscopic appendicectomy at Manly and Mona Vale Hospitals (Sydney, Australia) was analysed with regard to clinical assessment and outcomes. The primary endpoint was histological confirmation of acute appendicitis (AA). Secondary endpoints were length of hospital stay, NAR, correlation between preoperative WBC and AA, and sensitivity of preoperative imaging. RESULTS: A total of 501 patients were included in the study. AA was confirmed in 91.2% of patients. The NAR was 8.8% across all subgroups. The NAR was 12.1% in women. 95.6% of patients had preoperative imaging. There was a statistically significant relationship between WBC and length of stay (P < 0.005), with elevated WBC correlating with increasing length of stay. CONCLUSION: We concluded that preoperative WBC when elevated can be used as a marker for AA and also as a predictor for length of stay in hospital. We would also advocate the use of preoperative imaging in young women and children.

Estudio comparativo de marcadores bioquímicos de salud, en dos grupos etarios de docentes universitarios, 2017 / Comparative study of biochemical health markers, in two groups of university professors of the same age group, 2017

Objetivo: Comparar los valores de los marcadores bioquímicos sanguíneos: ácido úrico, creatinina, glucosa, colesterol y triglicéridos, entre dos grupos de docentes universitarios aparentemente sanos. Métodos: El primer grupo, formado por 58 docentes de 60 a 64 años y, el segundo por 35 docentes de 75 a 81 años; para evaluar si hay diferencia estadística significativa entre ambos grupos. Resultados: Los valores de ácido úrico en el grupo I estuvieron entre 2,50 mg/dL. y 8,20 mg/dL, y en el grupo II entre 2,50 mg/dL y 8,63 mg/dL, con diferencia significativa (p=0.035). Los valores de creatinina en el grupo I estuvieron entre 0,64 mg/dL y 1,56 mg/dL, y en el grupo II entre 0,80 mg/dL y 1,61 mg/dL., con diferencia significativa (p=0.004). Los valores de glucosa en el grupo I estuvieron entre 63 mg/dL y 188 mg/dL, y en el grupo II entre 60 mg/dL y 297 mg/dL, sin encontrar diferencia significativa (p=0.671). Los valores de colesterol en el grupo I estuvieron entre 125 mg/dL y 265 mg/ dL, y en el grupo II entre 107 mg/dL y 244 mg/dL, sin encontrar diferencia significativa (p=0.053). Los valores de triglicéridos en el grupo I estuvieron entre 58 mg/dL y 507 mg/dL, y en el grupo II entre 68 mg/dL y 314 mg/ dL, sin encontrar diferencia significativa (p=0.104). Conclusión: En los marcadores bioquímicos de ácido úrico y creatinina hay diferencia significativa entre ambos grupos etarios. En cambio, en los marcadores de glucosa, colesterol y triglicéridos, no se demuestra diferencia significativa entre ambos grupos etarios.

Objective: Compare the values of the blood biomakers: uric acid, creatinine, glucose, cholesterol and triglycerides, in two groups of university professors apparently healthy. Methods: The first group, formed by 58 professors aged 60 to 64, and the second formed by 35 professors aged 75 to 81, in order to evaluate if there is a significant statistic difference in both groups. Results: The values of uric acid in group I were between 2,50 mg/dL. and 8,20 mg/dL; in groups II were between 2,50 mg/dL and 8,63 mg/dL, showing a significant difference (p=0.035). The values of creatinine in group I were between 0,64 mg/dL and 1,56 mg/dL; and in group II were between 0,80 mg/ dL and 1,61 mg/dL., showing a significant difference (p=0.004). The values of glucose in group I were between 63 mg/dL and 188 mg/dL; and in group II were between 60 mg/dL y 297 mg/dL, not showing significant difference (p=0.671). The values of cholesterol in group I were between 125 mg/dL and 265 mg/dL; and in group II were between 107 mg/dL and 244 mg/dL; not showing significant difference (p=0.053). The values of triglycerides in group I were between 58 mg/dL and 507 mg/dL; and in group II were between 68 mg/dL and 314 mg/dL; not showing significant difference (p=0.104). Conclusion: There is a significant difference in the biomarkers of uric acid and creatinine between the age groups; however, there was not found significant difference in the biomarkers of glucose, cholesterol and triglycerides between the age groups.

Comparison of serum biochemical markers in patients with mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos.

BACKGROUND: In this study, we aimed to compare serum biochemical markers in patients with malignant pleural mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos. METHODS: Between September 01, 2010 and March 31, 2011, a total of 540 participants (354 males, 186 females; mean age 61.4 years; range, 35 to 89 years) were included in the study. The participants were divided into four groups as follows: (1) patients with pleural plaques (n=277); (2) healthy individuals with normal chest X-rays who were exposed to environmental asbestos (n=121); (3) healthy individuals with normal chest X-rays who were not exposed to environmental asbestos (n=118); and (4) patients with malignant pleural mesothelioma (n=24). Serum levels of carcinoembryonic antigen, cancer antigen 125, 15-3, 19-9, free T3, free T4, thyroidstimulating hormone, vitamin B12, folate, and ferritin were measured. RESULTS: Serum cancer antigen 125, 15-3, folic acid, vitamin B12, and ferritin levels were higher with lower free T3 levels in Group 4 than the other groups. The areas under the curve for cancer antigen 125 and 15-3 were 0.78 and 0.67, respectively in the differential diagnosis of mesothelioma from other pathologies (p<0.001 for both). Optimal limits of these biomarkers were 13.63 and 18.43 ng/mL, respectively with 83% and 75% sensitivity and 69% and 48% specificity, respectively. CONCLUSION: The combination or individual use of serum cancer antigen 125, 15-3, folic acid, vitamin B12, and ferritin levels may be helpful for early diagnosis and treatment of malignant pleural mesothelioma.

Avaliação da atividade da enzima glutationa-s-transferase da minhoca Eisenia foetida exposta à ivermectina / Evaluation of glutatione-s-transferase enzyme activity of the earthworm Eisenia foetida exposed to ivermectin

Muitos tipos de drogas são usados na medicina veterinária para controlar e melhorar a saúde animal através de tratamentos terapêuticos e profiláticos. A desvantagem desta prática é que os produtos farmacêuticos e seus metabólitos são liberados no ambiente e podem influenciar a fauna do solo através da excreção do esterco ou pela posterior aplicação ao campo agrícola. As avermectinas são vastamente utilizadas na medicina veterinária e na agricultura. Estudos anteriores demonstraram que a ivermectina (IVM), um parasiticida amplamente utilizado, é muito tóxico para diversas espécies de invertebrados não-alvo. Tendo em vista que a IVM é pouco metabolizada, excretada de forma relativamente inalterada e pela escassez de dados sobre a toxicidade aos invertebrados do solo, foram investigados, neste estudo, os efeitos agudos e crônicos deste parasiticida sobre a glutationa-s -transferase (GST) da oligoqueta Eisenia foetida. As minhocas Eisenia foetida foram expostas à concentrações de IVM a 0, 1, 5, 10, 50 e 100 mg kg-1, e as amostras foram tomadas nos dias 7, 14 e 28 para determinação da atividade da GST. Os resultados mostraram que a duração da exposição alterou significativamente os efeitos do parasiticida investigado sobre a atividade de GST. Especificamente, após uma redução inicial, o prolongamento da exposição causou a indução da atividade da GST. Com o aumento da concentração de IVM, as atividades da GST foram inibidas significativamente após 7 dias de exposição. Em particular, o efeito inibitório foi significativo nas concentrações mais elevadas de tratamento (10, 50 e 100 mg kg-1). Por outro lado, aos 14 e 28 dias foram observadas induções na atividade da enzima. A atividade da GST pode ser considerada como parâmetro sensível para avaliar a toxicidade da ivermectina para minhocas.

Many types of drugs are used in veterinary medicine to control and improve animal health through therapeutic and prophylactic treatments. The disadvantage of this practice is that pharmaceuticals and their metabolites are released into the environment and may influence soil fauna through manure excretion and subsequent application to agricultural field. The avermectins are extensively and increasingly used in veterinary medicine and agriculture. Previous studies have shown that ivermectin (IVM), a widely used parasiticide, is very toxic to many non-target invertebrate species. In view of the little metabolism and most of the ivermectin dose given to the animal is excreted, relatively unaltered, primarily in the feces and the scarcity of data on toxicity to soil invertebrates, acute and chronic effects of the parasiticide on the glutatione-s-transferase (GST) of the oligochaete Eisenia foetida were investigated. Earthworms of Eisenia foetida were exposed to IVM at 0, 1, 5, 10, 50 and 100 mg kg-1 concentrations; samples were taken at days 7, 14, and 28 exposure for determination of GST activities. The results showed that duration of the exposure significantly changed the effects of the investigated parasiticide on the GST activity. Namely, after the initial decrease, the prolongation of exposure caused the induction of the GST activity. With increasing IVM concentration, GST activities were inhibited significantly after 7 days of the exposure. In particular, the inhibition effect was significant at the higher treatment levels (10, 50 and 100 mg kg-1). On the other hand, at 14 and 28 days were observed inductions of enzyme activity. GST activity can be regarded as sensitive parameter for evaluating the toxicity of ivermectin to earthworms.